[[Request: Add Patanjali founding history to Patanjali section|Hello. I would like to request the following addition to the Patanjali section of this article. This is factual, well-sourced information currently missing from the article. Suggested addition: In 1995, Ramdev and Balkrishna founded the Divya Yoga Mandir Trust at Haridwar, under which they began manufacturing Ayurvedic medicines through Divya Pharmacy. Patanjali Ayurved Limited was co-founded by Ramdev and Balkrishna in 2006, headquartered in Haridwar. Balkrishna holds approximately 94 percent equity as managing director, while Ramdev holds no shares as a renunciate and serves as the public face of the enterprise. The broader Patanjali group reported a consolidated turnover of approximately ₹45,000 crore in FY2024. Sources: 1. Business Today, 15 September 2016 — businesstoday.in 2. Patanjali Ayurved Wikipedia article 3. markhub24.com, 24 February 2026 Thank you. Kunwwer (talk) 17:55, 16 April 2026 (UTC)]][reply]
| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 |
 | This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography | |
|
 | This article is within the scope of WikiProject Human rights, a collaborative effort to improve the coverage of Human rights on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Human rightsWikipedia:WikiProject Human rightsTemplate:WikiProject Human rightsHuman rights | | | Mid | This article has been rated as Mid-importance on the project's importance scale. |
|
|
 | The contentious topics procedure applies to this article. This article relates to COVID-19. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. |
The grammar for most of this article is atrocious. I'm trying to proofread it, albeit slowly, but every time I come back to the article I find poorly-written additions. Besides mechanistic issues, many claims are non-neutral, unsourced statements about Ramdev. Perhaps the page should be semi-protected to encourage editors to put a little more thought and work into their changes -- does anyone have thoughts on this? Morrowulf (talk) 4 July 2011 (EST)
Hello all,
Looking for discussion on two subsections within the controversies section of this article, I dont think they provide anything beneficial to the article.
- Rajiv Dixit subsection - I previously tried to clean this subsection up, but after thinking about its role in the page, its clear that this section offers a dispropriate space for a viewpoint of a small minority, and shouldn't be included in this article (please refer to WP:BLPBALANCE). The topic is given undue weight because this section presents an allegation made by a small minority as if it is an idea held by a larger group of people, please refer to WP:WEIGHT.
- Biography subsection - Is there evidence that he called for the halt in selling this? It's unclear to me how much of the information that is written currently in this section actually pertains to his involvement with it..
Open to thoughts, thanks :) RealPharmer3 (talk) 23:28, 28 March 2023 (UTC)[reply]
- Re Rajiv Dixit: NYTimes is a "viewpoint of a small minority"?
- Re Biography: Without searching RSN and POVN for discussions about the references, I'm wondering if it the section should be included. --Hipal (talk) 02:46, 29 March 2023 (UTC)[reply]
- Hi @Hipal,
- Rajiv Dixit: Well, the NYTimes article says, "Some of his friends believe that Ramdev resented Dixit’s own rising celebrity, and they publicly speculated about foul play. But the cardiac arrest was cited as the cause of death, and Ramdev has dismissed efforts to implicate him as a conspiracy by his political enemies." This information was published in the Times (not as its own article, only a couple sentences to mention it), and it clearly says that only a few held this opinion, so is there merit? Also, I don't believe there was enough evidence of his involvement in Dixit's death for further investigation either.
- Biography: I dont think this section should be kept, please let me know if you also agree. RealPharmer3 (talk) 23:47, 31 March 2023 (UTC)[reply]
- The NYTimes thought it worth including. We probably should as well. --Hipal (talk) 18:04, 6 April 2023 (UTC)[reply]
- Hi @RealPharmer3. Thank you for your contributions to this article! Regarding the Rajiv Dixit subsection, my opinion is that we delete it. I politely disagree with @Hipal - merely being published in the NYTimes is not valid grounds to include the topic in a Wikipedia article. This subsection could potentially be hearsay, may be contentious as the subject of this article is still living, and I could find no other credible sources that are still active. Looking forward to your thoughts. Ajay Platinum (talk) 02:20, 19 October 2024 (UTC)[reply]
- Removing the POV from a NYTimes article seems a POV violation.
- The issue isn't that it is just a POV from a NYTimes article, but that the NYTimes article is of high quality, not subject to WP:NEWSORGINDIA.
- What appears to be a problem is that there's no other mention of Dixit in this article. --Hipal (talk) 20:08, 19 October 2024 (UTC)[reply]
